TARA- Protara Therapeutics, Inc.

Name: Protara Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 26 sells. TARA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Shefferman Jesse	524.0K	$2.72M	-
CFO	Fabbio Patrick	175.0K	$907.4K	-
Other	Nicacio Leonardo Viana	158.0K	$819.2K	-
Other	Zummo Jacqueline	94.8K	$491.7K	-
Other	Conkling William	76.0K	$394.1K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 8, 2026	Zummo Jacqueline	Chief R&D Officer	Sell	1,134	$5.40	$6,123.60	-1.2%	-	-
May 14, 2025	Levy Richard S	Director	Buy	20,000	$3.19	$63,800.00	+64.5%	-1.9%	-
Mar 26, 2025	Zummo Jacqueline	Chf Scientific Operations Off	Sell	21,224	$4.53	$96,144.72	-17.7%	-32.5%	+14.6%
Sep 12, 2024	Opaleye Management Inc.59	10% Owner	Sell	158,901	$1.71	$271,715.44	-3.7%	+261.3%	+81.5%
Sep 10, 2024	Opaleye Management Inc.59	10% Owner	Sell	61,992	$1.84	$114,250.89	-1.4%	+285.5%	+79.8%
Jul 16, 2024	Opaleye Management Inc.59	10% Owner	Sell	11,396	$2.44	$27,827.89	-0.5%	-24.2%	+31.3%
Jul 11, 2024	Opaleye Management Inc.59	10% Owner	Sell	74,551	$2.36	$175,841.82	-1.1%	-27.8%	+30.3%
Jul 1, 2024	Opaleye Management Inc.59	10% Owner	Sell	8,288	$2.12	$17,597.91	-0.4%	-12.4%	+34.0%
Jun 28, 2024	Opaleye Management Inc.59	10% Owner	Sell	64,568	$2.21	$142,502.70	-1.4%	-12.0%	+38.5%
Jun 25, 2024	Opaleye Management Inc.59	10% Owner	Sell	12,725	$2.26	$28,734.32	-0.5%	-10.0%	+37.6%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC